The genomic landscape of urothelial carcinoma with high and low ERBB2/HER2 expression.

被引：0
|
作者：
Hadadi, Agreen
Krause, Harris
Elliott, Andrew
Farrell, Alex Patrick
Brown, Jacqueline T.
Nazha, Bassel
Harik, Lara
Carthon, Bradley Curtis
Nabhan, Chadi
Barata, Pedro C.
Saleh, Mohamed
Yang, Yuanquan
Korn, W. Michael
Mckay, Rana R.
Bilen, Mehmet Asim
机构：
[1] Emory Univ, Dept Hematol & Med Oncol, Sch Med, Atlanta, GA USA
[2] Caris Life Sci, Irving, TX USA
[3] Caris Life Sci, Phoenix, AZ USA
[4] Emory Univ, Dept Pathol, Sch Med, Atlanta, GA USA
[5] Univ Hosp Seidman Canc Ctr, Dept Internal Med, Cleveland, OH USA
[6] Ohio State Univ, Comprehens Canc Ctr, Columbus, OH USA
[7] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
555
引用
收藏
页数：1
相关论文
共 50 条
  • [21] TARGETING ERBB2 MUTATIONS IN UROTHELIAL CARCINOMA
    Audenet, Francois
    Isharwal, Sumit
    Arcila, Maria
    Funt, Samuel
    Rosenberg, Jonathan
    Bajorin, Dean
    Cha, Eugene
    Donahue, Timothy
    Donat, Machele
    Herr, Harry
    Dalbagni, Guido
    Bochner, Bernard
    Berger, Michael
    Al-Ahmadie, Hikmat
    Solit, David
    Iyer, Gopa
    [J]. JOURNAL OF UROLOGY, 2017, 197 (04): : E643 - E644
  • [22] The prognostic significance of HER2 expression in urothelial carcinoma
    Rosli, Nurwahyuna
    Mahasin, Mazne
    Saleh, Muhamad Fakhri M. O. H. D.
    ABD Shukor, Nordashima
    [J]. MALAYSIAN JOURNAL OF PATHOLOGY, 2022, 44 (02) : 245 - 252
  • [23] HER2 protein expression in urothelial carcinoma of the bladder
    Nikolaidou, A.
    Balis, G. C.
    Moustakas, G.
    Michalopoulou, E.
    Themeli, I.
    Demertzidis, G.
    Dimasis, N.
    [J]. VIRCHOWS ARCHIV, 2012, 461 : S295 - S295
  • [24] Detection of ERBB2 Amplification by Next-Generation Sequencing Predicts HER2 Expression in Colorectal Carcinoma
    Cenaj, Odise
    Ligon, Azra H.
    Hornick, Jason L.
    Sholl, Lynette M.
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2019, 152 (01) : 97 - 108
  • [25] The overexpression of a single oncogene (ERBB2/HER2) alters the proteomic landscape of extracellular vesicles
    Amorim, Maria
    Fernandes, Gustavo
    Oliveira, Paulo
    Martins-de-Souza, Daniel
    Dias-Neto, Emmanuel
    Nunes, Diana
    [J]. PROTEOMICS, 2014, 14 (12) : 1472 - 1479
  • [26] Quantitative measurement of HER2 expression to subclassify ERBB2 unamplified breast cancer
    Moutafi, Myrto
    Robbins, Charles J.
    Yaghoobi, Vesal
    Fernandez, Aileen, I
    Martinez-Morilla, Sandra
    Xirou, Vasiliki
    Bai, Yalai
    Song, Yan
    Gaule, Patricia
    Krueger, Joseph
    Bloom, Kenneth
    Hill, Salisha
    Liebler, Daniel C.
    Fulton, Regan
    Rimm, David L.
    [J]. LABORATORY INVESTIGATION, 2022, 102 (10) : 1101 - 1108
  • [27] ERBB2 (HER2) Mutation Spectrum in Solid Tumors
    Wen, W.
    Chen, W.
    Millis, S.
    Bender, R.
    Ghazalpour, A.
    Tan, Z.
    Basu, G.
    Gatalica, Z.
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2013, 15 (06): : 917 - 917
  • [28] Inhibition of ErbB2(Her2) expression with small molecule transcription factor mimics
    Lee, Lori W.
    Taylor, Christopher E. C.
    Desaulniers, Jean-Paul
    Zhang, Manchao
    Hojfeldt, Jonas W.
    Pan, Quintin
    Mapp, Anna K.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (21) : 6233 - 6236
  • [29] Acral lentiginous melanoma with HER2/ErbB2 amplification
    Marie Donzel
    Olivier Harou
    François Skowron
    Stéphane Dalle
    Françoise Descotes
    Brigitte Balme
    Jonathan Lopez
    [J]. European Journal of Dermatology, 2021, 31 : 588 - 590
  • [30] Pan-cancer analysis of the influence of ERBB2 alteration on HER2 expression
    Lee, Taebum
    Shin, Sangwon
    Song, Heon
    Park, Seonwook
    Pereira, Sergio
    Yoo, Donggeun
    Ro, Juneyoung
    Moon, Jimin
    Cho, Soo Ick
    Ahn, Changho
    Ock, Chan-Young
    Ali, Siraj M.
    [J]. CANCER RESEARCH, 2024, 84 (06)
12345